Accueil / Tag Archives: Genetics

Tag Archives: Genetics

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Monday, March 20th 2017 at 2:00pm UTC First study of a liquid biopsy to predict response to immunotherapy Highly accurate with a PPV of 92% and 100% for progression after one and two cycles respectively Early discovery of treatment-induced hyper-progressive disease Published in the peer-reviewed journal, Clinical Cancer Research SAN …

Plus »

Variantyx Launches Genomic Intelligence® Clinical Diagnostic Platform

Tuesday, March 21st 2017 at 1:00pm UTC FRAMINGHAM, Mass.–(BUSINESS WIRE)– Variantyx announced the US launch of its proprietary clinical diagnostic platform at the American College of Medical Genetics (ACMG) conference in Phoenix, AZ. The Genomic Intelligence® platform automates the complete NGS testing process from sample collection to sequencing, data analysis, …

Plus »

Syros Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Monday, March 20th 2017 at 12:01pm UTC – Presented Data at Key Medical Meetings Further Supporting Therapeutic Potential of SY-1425 in Genomically Defined AML, MDS and Breast Cancer Patients – – Highlighted Data at Scientific Conferences Demonstrating Productivity of Syros’ Gene Control Platform in Oncology and Immuno-oncology – – On …

Plus »

Therachon Appoints Dr. Maarten Kraan, Ph.D., M.D., Chief Medical Officer

Tuesday, March 21st 2017 at 11:00am UTC BASEL, Switzerland–(BUSINESS WIRE)– Therachon AG, a biotechnology company focused on rare genetic diseases, announced today it has appointed Dr. Maarten Kraan, Ph.D., M.D., to the role of Chief Medical Officer. “We are delighted to welcome Dr. Kraan as Therachon’s Chief Medical Officer,” said …

Plus »

NightstaRx Commences first Phase I/II Gene Therapy Clinical Trial for Patients with X-Linked Retinitis Pigmentosa

Monday, March 20th 2017 at 12:01am UTC Second NightstaRx AAV Product Candidate in Patient Testing LONDON–(BUSINESS WIRE)– NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, today announces that the Company has commenced enrolling and dosing subjects in a Phase I/II clinical trial to …

Plus »

SCIEX and the Children’s Medical Research Institute Announce Opening of ProCan to Advance Precision Medicine

Tuesday, March 21st 2017 at 11:00am UTC SCIEX industrialized proteomics solutions, using microflow SWATH Acquisition, will accelerate cancer research FRAMINGHAM, Mass. & SYDNEY–(BUSINESS WIRE)– SCIEX, a global leader in life science analytical technologies, has announced that Children’s Medical Research Institute (CMRI) has opened ProCan™, the Australian Cancer Research Foundation International …

Plus »

Selexis Announces Launch of Novel Cell Selection Platform Designed to Help Advance Difficult-to-Express Protein Therapeutics to the Clinic

Monday, March 20th 2017 at 7:00am UTC SUREselect can improve the quality of clone selection for cell lines used to manufacture protein therapeutics and vaccines GENEVA–(BUSINESS WIRE)– Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, announced today the launch of …

Plus »

Castle Biosciences’ DecisionDx-Melanoma Test Shown to be a Significant Predictor of Distant Metastasis in Elderly Patients with Melanoma

Monday, March 20th 2017 at 12:00pm UTC Additional independent studies presented at the 70th Society of Surgical Oncology Annual Cancer Symposium confirm performance and clinical impact of test FRIENDSWOOD, Texas–(BUSINESS WIRE)– Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that studies evaluating the prognostic performance and …

Plus »

Rosetta Genomics Fortifies Patent Protection for its Unique RosettaGX RevealTM Assay

Monday, March 20th 2017 at 12:00pm UTC Allowance for U.S. Patent that Covers the Company’s differentiated assay for the diagnosis of thyroid cancer PHILADELPHIA & REHOVOT, Israel–(BUSINESS WIRE)– Rosetta Genomics Ltd. (NASDAQ:ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, today …

Plus »

BioTime to Present at Oppenheimer 27th Annual Healthcare Conference

Monday, March 20th 2017 at 11:00am UTC ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Russell Skibsted, Chief Financial Officer, will be presenting at the Oppenheimer 27th Annual Healthcare Conference at the Westin Grand Central in New …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...